UAE Medical Devices Market By Type (Cardiovascular Devices, Diagnostic Imaging Equipment, In-vitro Diagnostic Devices, Ophthalmic Devices, Diabetes Care Devices, Dental Care Devices, Surgical Equipment, Patient Monitoring Devices, Orthopedic Devices, Nephrology & Urology Devices, ENT Devices, Anesthesia & Respiratory Devices, Neurology Devices, Mobility-Aid Devices, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Region, Competition, Forecast & Opportunities, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 1.94 BIllion
CAGR (2026-2031)	6.18%
Fastest Growing Segment	Surgical Equipment
Largest Market	Abu Dhabi
Market Size (2031)	USD 2.78 BIllion

Market Overview

The UAE Medical Devices Market will grow from USD 1.94 BIllion in 2025 to USD 2.78 BIllion by 2031 at a 6.18% CAGR. Medical devices encompass a broad spectrum of instruments, apparatuses, and implants utilized for the diagnosis, prevention, monitoring, and treatment of medical conditions. The market growth in the UAE is primarily supported by the rising prevalence of chronic lifestyle diseases such as diabetes and cardiovascular disorders which necessitate continuous medical intervention. Furthermore, the strategic government expansion of healthcare infrastructure to support medical tourism and the broadening of mandatory health insurance coverage provide a strong foundation for sector development. According to Mecomed, in 2024, the medical devices segment in the UAE was projected to reach a value of USD 2.61 billion.

A significant challenge that could impede market expansion is the substantial reliance on imports for the majority of medical equipment. This dependency on international manufacturers exposes the local market to global supply chain disruptions and fluctuating logistics costs which limits the domestic control over the availability and affordability of essential technologies.

Key Market Drivers

The expansion of the UAE as a regional medical tourism hub serves as a primary catalyst for the medical devices market, driving demand for advanced diagnostic equipment and surgical instruments. To maintain competitiveness against global destinations, local healthcare facilities are aggressively upgrading their technological capabilities, particularly in elective specialties such as orthopedics, dermatology, and cosmetic surgery. This influx of international patients necessitates the procurement of high-volume consumables and state-of-the-art apparatuses to ensure premium care standards. According to the Dubai Health Authority, April 2024, in the 'Dubai Health Sector Annual Report', the emirate successfully attracted 691,000 medical tourists in 2023, significantly increasing the utilization rates of medical assets across private and public hospitals. This sustained flow of inbound patients ensures a continuous revenue stream for device suppliers, specifically those providing specialized technologies required for aesthetic and reconstructive procedures.

Industrial initiatives promoting domestic manufacturing localization are simultaneously reshaping the market structure by reducing historical reliance on imports and encouraging local production. The government has implemented favorable policies, such as the "Make it in the Emirates" campaign, which incentivizes healthcare conglomerates to source products from within the country, thereby strengthening the local supply chain against global disruptions. According to the Ministry of Industry and Advanced Technology, May 2024, in a press statement regarding the 'Make it in the Emirates Forum', PureHealth committed to allocating AED 13 billion towards local procurement over the next decade to support domestic industrial capabilities. These localization efforts are further bolstered by consistent public funding which ensures the ecosystem remains viable for new market entrants. According to the UAE Cabinet, October 2024, the federally approved general budget for the fiscal year 2025 allocated AED 5.7 billion specifically to the healthcare and community protection sector, securing the financial foundation necessary for these industrial advancements.

Download Free Sample Report

Key Market Challenges

The substantial reliance on imports for the majority of medical equipment fundamentally restricts the stability and autonomous control of the UAE market. Because the domestic manufacturing sector is still in its nascent stages, the availability of critical medical technologies is dictated by international trade dynamics rather than local demand. This dependency forces healthcare providers to absorb fluctuating logistics costs and currency exchange variances, which inevitably drives up the price of essential devices. Consequently, this financial unpredictability can delay procurement cycles and limit the adoption of advanced technologies by smaller healthcare facilities that cannot afford the premium associated with imported goods, thereby creating a fragmented market environment.

This vulnerability is further intensified by the sector's rapid expansion trajectory, which demands a consistent and increasing inflow of supplies that international supply chains may struggle to meet during global disruptions. According to Mecomed, in 2024, the regional MedTech market was forecast to grow at a compound annual growth rate of 8.59% through 2029. This projected surge in demand underscores the widening gap between consumption and local production capabilities. As the market expands, the continued absence of a robust domestic supply chain exacerbates the exposure to external shocks, creating a bottleneck that hampers the sustainable, long-term efficiency of the industry.

Key Market Trends

The integration of AI-powered diagnostic and imaging systems is fundamentally altering the operational landscape of the UAE medical devices market by shifting the focus from hardware accumulation to software-driven analytical precision. Healthcare providers are increasingly deploying algorithms that enhance imaging clarity and automate the detection of anomalies, which significantly accelerates clinical decision-making and reduces diagnostic errors. This technological convergence is exemplified by major institutional investments aimed at centralizing pathology and radiology services through intelligent platforms that can process vast datasets more efficiently than traditional methods. According to Middle East AI News, December 2025, in the 'PureHealth launches UAE's largest AI-powered diagnostic laboratory' article, PureHealth inaugurated a 70,000-square-foot flagship facility developed under its subsidiary PureLab, which utilizes advanced artificial intelligence to streamline testing processes and improve diagnostic accuracy for the region.

The rapid adoption of robotic-assisted and minimally invasive surgical technologies is simultaneously redefining procedural standards across the Emirates' tertiary care network. Hospitals are aggressively acquiring advanced robotic systems to facilitate complex operations in urology, oncology, and cardiology, thereby minimizing patient recovery times and surgical trauma. This trend is driven by a clinical mandate to offer remote and high-precision interventions that were previously unavailable domestically, expanding the scope of what is surgically possible within the country. According to Middle East Health, September 2025, in the 'AI and robotics in healthcare' report, Cleveland Clinic Abu Dhabi achieved a significant milestone by successfully performing the first-ever transcontinental robotic-assisted focal therapy procedure, where the operation was guided in real-time by a surgeon located in the United States.

Segmental Insights

According to recent industry research, the Surgical Equipment segment is the fastest-growing category within the UAE Medical Devices Market, driven by the nation's rapid expansion of hospital infrastructure. This robust growth is primarily fueled by the increasing prevalence of chronic lifestyle diseases requiring intervention and the strategic development of medical tourism, which generates consistent demand for operative tools. Additionally, the widespread adoption of minimally invasive procedures has accelerated the need for specialized instrumentation. The Ministry of Health and Prevention supports this trajectory through established regulatory frameworks that facilitate the integration of compliant, high-quality technologies into the healthcare system.

Regional Insights

Abu Dhabi holds the dominant position in the UAE medical devices market, driven by substantial government funding and expanded healthcare infrastructure. The Department of Health – Abu Dhabi (DoH) plays a critical role by enforcing standardized regulations that encourage the adoption of modern medical equipment. Additionally, strategic investments from organizations such as Mubadala Health actively support the development of large-scale hospital projects, securing continuous demand for imported and locally manufactured devices. This combination of regulatory clarity and capital allocation establishes Abu Dhabi as the central region for market expansion.

Recent Developments

• In July 2025, Dubai Health and GE HealthCare entered into a strategic collaboration to advance medical imaging capabilities within the UAE medical devices market. The partnership focused on establishing a Center of Excellence for Point-of-Care Ultrasound (POCUS) education at the Mohammed Bin Rashid University of Medicine and Health Sciences. Furthermore, the agreement included the co-development of artificial intelligence solutions intended to support clinical decision-making and diagnostic accuracy. This initiative was designed to equip healthcare professionals with specialized technical skills and integrate cutting-edge diagnostic tools into daily practice, thereby elevating the standard of patient care in Dubai.
• In May 2024, M42, a technology-enabled healthcare holding company based in Abu Dhabi, launched AIRIS-TB, an AI-powered medical screening tool designed to enhance tuberculosis detection. This breakthrough solution utilizes advanced artificial intelligence algorithms to analyze chest X-rays, providing rapid and accurate assessments to support mass screening initiatives. The introduction of this device software aligned with national and global public health goals to eradicate tuberculosis by 2030. By integrating this technology into the local healthcare ecosystem, the company aimed to improve diagnostic capabilities and facilitate early intervention for patients across the United Arab Emirates and beyond.
• In February 2024, 3DMakerpro Medical expanded its portfolio in the UAE by launching innovative dental scanning solutions at the AEEDC Dubai Conference. The technology company debuted the JMO1 intraoral 3D scanner, a device engineered to provide superior user experience and operational efficiency for dental professionals. Alongside this primary launch, the firm showcased its JMA1 desktop scanner and JMM1 handheld body scanner, while also previewing upcoming facial scanning technology. This strategic move aimed to accelerate the adoption of digital dental care in the Emirates, offering practitioners high-precision tools to optimize clinical workflows and improve treatment outcomes.
• In January 2024, Siemens Healthineers introduced advanced diagnostic imaging systems to the UAE medical devices market during the Arab Health exhibition in Dubai. The company unveiled the SOMATOM Pro.Pulse, a dual-source computed tomography system designed to deliver high-precision scanning for diverse medical specialties while maintaining cost efficiency for healthcare facilities. Additionally, the company debuted the Magnetom Free.Max in the Middle East, a magnetic resonance scanner featuring a virtually helium-free infrastructure and a compact design. These product launches underscored the organization's strategy to enhance patient access to state-of-the-art diagnostic technologies and support sustainable healthcare operations in the region.

Key Market Players

• GE Healthcare (Middle East)
• MINDRAY MEDICAL MIDDLE EAST - FZE
• Siemens UAE
• Philips Healthcare UAE
• Hitachi Medical Systems Middle East S.A.E.
• Shimadzu Middle East & Africa FZE
• Fujifilm Middle East FZE
• Medtronic (UAE)
• Johnson & Johnson Middle East
• Abbott Laboratories S.A.

By Type	By End User	By Region
Cardiovascular Devices Diagnostic Imaging Equipment In-vitro Diagnostic Devices Ophthalmic Devices Diabetes Care Devices Dental Care Devices Surgical Equipment Patient Monitoring Devices Orthopedic Devices Nephrology & Urology Devices ENT Devices Anesthesia & Respiratory Devices Neurology Devices Mobility-Aid Devices Others	Hospitals & Clinics Diagnostic Centers Others	Abu Dhabi Dubai Sharjah Rest of UAE

Report Scope:

In this report, the UAE Medical Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• UAE Medical Devices Market, By Type:

• Cardiovascular Devices
• Diagnostic Imaging Equipment
• In-vitro Diagnostic Devices
• Ophthalmic Devices
• Diabetes Care Devices
• Dental Care Devices
• Surgical Equipment
• Patient Monitoring Devices
• Orthopedic Devices
• Nephrology & Urology Devices
• ENT Devices
• Anesthesia & Respiratory Devices
• Neurology Devices
• Mobility-Aid Devices
• Others

• UAE Medical Devices Market, By End User:

• Hospitals & Clinics
• Diagnostic Centers
• Others

• UAE Medical Devices Market, By Region:

• Abu Dhabi
• Dubai
• Sharjah
• Rest of UAE